Hepatitis Testing/Diagnosis Market research report by Delvens focuses on primary sections such as – market segments, market outlook, competitive landscape, and company profiles. The segments provide details in terms of various perspectives such as end-use industry, product or service type, and any other relevant segmentation as per the market’s current scenario which includes various aspects to perform further marketing activity, the global hepatitis testing market is projected to reach USD 2.8 billion in 2021, at a CAGR of 6.7% during the forecast period.
Get Free Sample Report: https://www.delvens.com/get-free-sample/hepatitis-testing-market
Recent Developments
Abbott received FDA Emergency Use Authorization (EUA) for the Alinity m Resp-4-Plex assay.
F.Hoffmann-La Roche Ltd. acquired GenMark Diagnostics (US) which aimed at adding more products to Roche’s molecular diagnostics portfolio and the global distribution of products offered by GenMark Diagnostics.
Regional Analysis
North America dominates the global market, and this trend is expected to continue during the forecast period. The large share and high growth of this region can be attributed to the rising prevalence of hepatitis and increased research and clinical trials for hepatitis testing in the US.
Key Players of Hepatitis Testing/Diagnosis Market:
- Abbott Laboratories
- Danaher Corporation
- BioMerieux SA
- Bio-Rad Laboratories Inc
- Diasorin S.p.A
- Hoffmann-La Roche AG
- Hologic Inc
- MedMira Inc
- Qaigen Inc
- Siemens Healthineers and More
Hepatitis Testing/Diagnosis Market is segmented into disease type, technology, end user and region.
On the basis of Disease Type
- Hepatitis B (HBV)
- Hepatitis C (HCV)
On the basis of Technology
- Enzyme-linked Immunosorbent Assay (ELISA)
- Rapid Diagnostic Tests (RDT)
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
On the basis of End-User
- Hospital & Diagnostic Laboratories
- Blood Banks
On the basis of Region
- Asia Pacific
- North America
- Europe
- South America
- Middle East & Africa
Access More Reports: https://www.delvens.com/report/hepatitis-testing-market
In addition to the market data for Hepatitis Testing/Diagnosis Market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement.
Reasons to Acquire
- Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors
- Gain authentic and granular data access for Hepatitis Testing/Diagnosis Market so as to understand the trends and the factors involved behind changing market situations
- Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
- In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns
Access More Reports:
About Us:
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.
Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
Contact us:
Unit No. 01, 3rd Floor, Plot No. 56, Block B
Sector 2 Noida, Near Noida Sector 15 Metro Station 201301, IN
+44 20 3290 6466
+0120- 4903958
